In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices

Xenobiotica

Volumn 27, Issue 5, 1997, Pages 431-441

  McNeilly, P J ^a   Torchin, C D ^b   Anderson, L W ^a   Kapetanovic, I M ^b   Kupferberg, H J ^b   Strong, J M ^a  

^a Ctr for Drug Eval and Research   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DRUG METABOLITE; RETIGABINE;

ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG OXIDATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER MICROSOME; LIVER SLICE;

ANTICONVULSANTS; CARBAMATES; DRUG EVALUATION, PRECLINICAL; GLUCURONATES; HUMANS; KINETICS; LIVER; MICROSOMES, LIVER; PHENYLENEDIAMINES; REGRESSION ANALYSIS;

EID: 0030991641     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982597240424     Document Type: Article

References (22)

1. BABU, S. R., LAKSHMI, V.M., ZENSER, T. V. and DAVIS, B. B., 1994, Glucuronidation of N-acetylbenzidine by human liver. Drug Metabolism and Disposition, 22, 922-927.
2. DAHL-PUUSTINEN, M. and BERTILSSON, L., 1987, Formation of a quaternary N-glucuronide of amitriptyline in human liver microsomes. Pharmacology and Toxicology, 61, 342-346.
3. DOGTEROM, P., 1993, Development of a simple incubation system for metabolism studies with precision-cut liver slices. Drug Metabolism and Disposition, 21, 699-703.
4. GREEN, M. D., BISHOP, W. P. and TEPHLY, T. R., 1995, Expressed human UGT1·4 protein catalyzes the formation of quarternary ammonium linked glucuronides. Drug Metabolism and Disposition, 23, 299-302.
5. HARRIS, J. W., RAHMAN, A., KIM, B., GUENGERICH, F. P. and COLLINS, J. M., 1994, Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Research, 54, 4026-4035.
6. HLAVICA, P. and NIEBCH, G., 1985, Untersuchungen zur Pharmakokinetik und Biotransformation des Analgetikums Flupirtin beim Menschen. Arzneim.-Forsch./Drug Research, 35, 67-74.
7. HUSKEY, S. W., MAGDALOU, J., OUZZINE, M., SIEST G. and CHIU, S. L., 1994, N-glucuronidation reactions III: regioselective N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyl-transferases stably expressed in V79 cells. Drug Metabolism and Disposition, 22, 659-662.
8. HUSKEY, S. W., MILLER, R. R. and CHIU, S. L., 1993, N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys and humans. Drug Metabolism and Disposition, 21, 792-799.
9. JAMIS-DOW, C. A., KLECKER, R. W., KATKI, A. G. and COLLINS, J. M., 1995, Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences. Cancer Chemotherapy and Pharmacology, 36, 107-114.
10. KAPETANOVIC, I. M. and RUNDFELDT, C., 1996, D-23129 - A new anticonvulsant compound. CNS Drug Reviews, 2, 308-321.
11. KAPETANOVIC, I. M., YONEKAWA, W. D. and KUPFERBERG, H. J., 1995, The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro. Epilepsy Research, 22, 167-173.
12. MAGDALOU, J., HERBER, R., BIDAULT, R. and SIEST, G., 1992, In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 260, 1166-1173.
13. OBERMEIER, K., NIEBCH, G. and THIEMER, K., 1985, Untersuchungen zur Pharmakokinetik und Biotransformation des Analgetikums Flupirtin bei Ratte und Hund. Arzneim.-Forsch./Drug Research, 35, 60-67.
14. ORZECHOWSKI, A., SCHRENK, D., BOCK-HENNING, B. S. and BOCK, K. W., 1994, Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Carcinogenesis, 15, 1549-1553.
15. PORTER, R. J., 1993, Classification of epileptic seizures and epileptic syndromes. In A Textbook of Epilepsy, edited by J. Laidlaw and D. Chadwick (New York: Churchill Livingstone) pp. 1-22.
16. RALL, T. W. and SCHLEIFER, L. S., 1990, Drugs effective in the therapy of the epilepsies. In The Pharmacological Basis of Therapeutics, 8th edition, edited by A. Goodman Gilman, T. W. Rall, A. S. Niles and P. Taylor (New York: Pergamon), pp. 436-462.
17. RAJAONARISON, J. F., LACARELLE, B., DESOUSA, G., CATALIN, J. and RAHMANI, R., 1991, In vitro glucuronidation of 3′-azido-3′-deoxythymidine by human liver. Drug Metabolism and Disposition, 19, 809-815.
18. REMEL, R. P. and SINZ, M. W., 1991, A quaternary ammonium glucuronide is the major metabolite of lamotrigine in guinea pigs. Drug Metabolism and Disposition, 19, 630-636.
19. ROSTOCK, A., TOBER, C., RUNDFELDT, C., BARTSCH, R., ENGEL, J., POLYMEROPOULOS, E., KUTSCHER, B., LOSCHER, W., HONACK, D., WHITE, H. S. and WOLF, H. H., 1996, D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Research, 23, 211-223.
20. SEYDEL, J. K., SCHAPER, K. J., COATS, E. A., CORDES, H. P., EMIG, P., ENGEL, J., KUTSCHER, B. and POLYMEROPOULOS, E. E., 1994, Synthesis and quantitative structure-activity relationships of anticonvulsant 2,3,6-triaminopyridines. Journal of Medicinal Chemistry, 37, 3016-3022.
21. WORBOYS, P. D., BRADBURY, A. and HOUSTON, J. B., 1995, Kinetics of drug metabolism in rat liver slices. Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds. Drug Metabolism and Disposition, 23, 393-397.
22. YONEKAWA, W. D., KAPETANOVIC, I. M. and KUPFERBERG, H. J., 1995, The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro. Epilepsy Research, 20, 137-150.